Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Cervical Cancer

  Free Subscription

Articles published in Diagn Cytopathol

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    November 2022
  1. LIN LH, Zhou F, Elishaev E, Khader S, et al
    Cervicovaginal cytology, HPV testing and vaginal flora in transmasculine persons receiving testosterone.
    Diagn Cytopathol. 2022;50:518-524.
    PubMed     Abstract available

    October 2022
  2. OKABE A, Ishida M, Noda Y, Okano K, et al
    Small-cell neuroendocrine carcinoma of the cervix accompanied by adenocarcinoma and high-grade squamous intraepithelial lesion.
    Diagn Cytopathol. 2022;50:E285-E288.
    PubMed     Abstract available

    August 2022
  3. ZHANG L, Qi R, Wang L, Jiang F, et al
    Clinical value of the ThinPrep cytologic test with E6/E7 mRNA detection for cervical cancer screening in disease diagnosis.
    Diagn Cytopathol. 2022 Aug 1. doi: 10.1002/dc.25025.
    PubMed     Abstract available

    July 2022
  4. CHO S, Lee SM, Lee S, Cho HW, et al
    The necessity of continuing cervical cancer screening of elderly Korean women aged 65 years or older.
    Diagn Cytopathol. 2022 Jul 30. doi: 10.1002/dc.25021.
    PubMed     Abstract available

  5. BESHARATI S, Liu-Jarin X, Chen X, Cimic A, et al
    An unusual case of carcinoma with mesonephric-like features with a spindle cell component diagnosed on the Pap test of the uterine cervix: Cytomorphologic and immunophenotypic features and diagnostic pitfalls.
    Diagn Cytopathol. 2022 Jul 2. doi: 10.1002/dc.25009.
    PubMed     Abstract available

    June 2022
  6. OKAYAMA K, Ishii Y, Fujii M, Oda M, et al
    Causation of cornflake artifacts: Possible association of poor dehydration with drying before mounting in Papanicolaou stain.
    Diagn Cytopathol. 2022 Jun 17. doi: 10.1002/dc.25002.
    PubMed     Abstract available

    May 2022
  7. NERSESYAN A, Parsadanyan G
    Re: "Cytomorphometry and morphology analysis of human papillomavirus type 16 in liquid-based cervical cytology samples" by Safi Oz et al.
    Diagn Cytopathol. 2022;50:263-264.

    December 2021
  8. ELEUTERIO J JR, Surima W, Lima MAT, Bezerra JVS, et al
    Liquid-based cytology and HPV DNA test in anal specimens from women with cervical cancer.
    Diagn Cytopathol. 2021 Dec 30. doi: 10.1002/dc.24925.
    PubMed     Abstract available

    September 2021
  9. KUMAR P, Gupta P, Dey P
    Cytodiagnosis of metastatic cervical low-grade endometrial stromal sarcoma presenting as bilateral adnexal masses.
    Diagn Cytopathol. 2021 Sep 28. doi: 10.1002/dc.24881.

    The importance of biomonitoring studies for detecting cytogenetic damage in cervical biopsy samples infected with human papillomavirus type 16.
    Diagn Cytopathol. 2021;49:1070-1071.

  11. SIVAKUMAR N, Narwal A, Kumar S, Kamboj M, et al
    Application of the Bethesda system of reporting for cervical cytology to evaluate human papilloma virus induced changes in oral leukoplakia, oral squamous cell carcinoma, and oropharyngeal squamous cell carcinoma: A cytomorphological and genetic study
    Diagn Cytopathol. 2021;49:1036-1044.
    PubMed     Abstract available

    August 2021
  12. SINCLAIR WD, Gibbons-Fideler IS, Shen R, Li Z, et al
    The reporting rates of high-grade squamous intraepithelial lesions and their human papillomavirus testing and histologic follow-up results: A comparison between ThinPrep and SurePath preparations.
    Diagn Cytopathol. 2021;49:959-963.
    PubMed     Abstract available

  13. RODRIGUEZ-VELASQUEZ JO, Barrios-Arroyave FA, Correa-Herrera SC, Grisales-Gutierrez CE, et al
    Fractal geometry applied to the analysis of cervix biopsy.
    Diagn Cytopathol. 2021;49:938-943.
    PubMed     Abstract available

    July 2021
  14. SAFI OZ Z, Onak Kandemir N, Kokturk F, Ozdamar SO, et al
    Cytomorphometry and morphology analysis of human papillomavirus type 16 in liquid-based cervical cytology samples.
    Diagn Cytopathol. 2021;49:885-893.
    PubMed     Abstract available

    April 2021
  15. KABACA C, Giray B, Guray Uzun M, Akis S, et al
    The meaning of high-risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?
    Diagn Cytopathol. 2021;49:480-486.
    PubMed     Abstract available

    March 2021
  16. MANTRI S, Ravikumar G, Crasta J
    Assessment of cytological features of glandular lesions of the cervix on conventional smear preparations-a comprehensive study from a tertiary care hospital.
    Diagn Cytopathol. 2021;49:388-394.
    PubMed     Abstract available

    February 2021
  17. REZENDE MT, Bianchi AGC, Carneiro CM
    Cervical cancer: Automation of Pap test screening.
    Diagn Cytopathol. 2021 Feb 6. doi: 10.1002/dc.24708.
    PubMed     Abstract available

  18. NEGRI G, Macciocu E, Cepurnaite R, Kasal A, et al
    Non-human papilloma virus associated adenocarcinomas of the cervix uteri. Cytologic features and diagnostic agreement using whole slide digital cytology imaging.
    Diagn Cytopathol. 2021;49:316-321.
    PubMed     Abstract available

  19. GIRAY B, Kabaca C, Uzun MG, Akis S, et al
    Is cervical cytology testing as a part of co-test unnecessary for HPV 16/18-infected women? A retrospective cohort study of 1647 women.
    Diagn Cytopathol. 2021;49:267-272.
    PubMed     Abstract available

  20. LIN Q, Lin X, Zhuang X, Tang Y, et al
    The prevalence, genotype distribution of human papillomavirus and cervical cytology in Wenzhou, China: a retrospective research of 7391 cases.
    Diagn Cytopathol. 2021;49:211-218.
    PubMed     Abstract available

    January 2021
  21. AYDOGAN KIRMIZI D, Baser E, Demir Caltekin M, Onat T, et al
    Concordance of HPV, conventional smear, colposcopy, and conization results in cervical dysplasia.
    Diagn Cytopathol. 2021;49:132-139.
    PubMed     Abstract available

  22. MEHTA SP, Patel TS, Jana T, Samanta ST, et al
    How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience.
    Diagn Cytopathol. 2021;49:127-131.
    PubMed     Abstract available

  23. WANG T, Pradhan D, Zhang H, Matsko J, et al
    Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Diagn Cytopathol. 2021;49:5-10.
    PubMed     Abstract available

    December 2020
  24. COSTA AF, Ribeiro MGM, Onofre ASC, de Miranda Onofre FB, et al
    Aneuploidy detection for diagnostic and prognostic use in premalignant and malignant lesions of the uterine cervix: A systematic review.
    Diagn Cytopathol. 2020 Dec 17:e24683. doi: 10.1002/dc.24683.
    PubMed     Abstract available

    October 2020
  25. AGARWAL P, Bakshi P, Verma K
    Liquid-based cytology of amoebic cervicitis clinically mimicking cervical cancer.
    Diagn Cytopathol. 2020 Oct 31. doi: 10.1002/dc.24628.

    August 2020
  26. CAMPANER AB, Fernandes GL
    Detection of transformation zone cells in liquid-based cytology and its comparison with conventional smears.
    Diagn Cytopathol. 2020;48:752-758.
    PubMed     Abstract available

  27. KANAI R, Ohshima K, Ishii K, Sonohara M, et al
    Discriminant analysis and interpretation of nuclear chromatin distribution and coarseness using gray-level co-occurrence matrix features for lobular endocervical glandular hyperplasia.
    Diagn Cytopathol. 2020;48:724-735.
    PubMed     Abstract available

    July 2020
  28. IKEGAMI K, Watanabe G, Kumagai J, Fujii Y, et al
    The apparition macrophage and Doderlein bacillus is negatively correlated in class I Papanicolaou smear: A morphological examination.
    Diagn Cytopathol. 2020 Jul 6. doi: 10.1002/dc.24538.
    PubMed     Abstract available

  29. LIU W, Gong J, Xu H, Zhang D, et al
    Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.
    Diagn Cytopathol. 2020;48:635-644.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.